Eye zap study seeks to prove what patients already feel
NCT ID NCT07548944
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with retinitis pigmentosa and similar eye diseases who already use a device called OkuStim® that sends mild electrical pulses to the eye. Many patients report temporary improvements in vision right after treatment, but these haven't been measured in a standard way. Researchers will test 30 adults using eye charts and other tools to see if these short-term benefits are real and can be tracked.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONE-ROD DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Augenzentrum Frankfurt Prof. Koch GmbH
RECRUITINGFrankfurt am Main, 60549, Germany
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an antioxidant pill slow blindness in usher syndrome?
- New eye camera could unlock secrets of inherited blindness
- Tiny genetic clues may unlock eye disease mysteries
- Thousands join fight against blindness by sharing their stories
- New eye scans could revolutionize how we see retinal disease
- New study seeks volunteers for future eye disease treatment